President Trump selected Susan Monarez, interim director of the centers for the control and prevention of diseases, to guide the agency permanently.
The president withdrew his first candidate, dr. Dave Weldon, a few hours before his confirmation hearing. If confirmed by the Senate, Dr. Monararez, a researcher of infectious diseases, will be the first non -physical to lead the agency in over 50 years.
“The Americans have lost confidence in the CDC due to political prejudices and disastrous bad management”, wrote the president on Truth Social, adding that Dr. Monaarez would have worked with the secretary of health, Robert F. Kennedy Jr., to face the epidemic of chronic diseases and restore the responsibility of the agency.
“As an incredible mother and public employee dedicated, Dr. Monorarez includes the importance of protecting our children, our communities and our future,” wrote Trump.
Dr. Monorarez, 50, took the position of interim director a few days after Trump came in office in January, leaving his trespolo as deputy director of a new federal biomedical research agency during the Biden administration.
Dr. Monazz should have served until the first choice of Mr. Trump for work, Dr. Weldon, could be confirmed. But after Mr. Trump decided to withdraw the appointment, the Republican assistants in the Senate said that dr. Weldon had not been able to impress with a plan for the agency.
Dr. Weldon has blamed two republican senators – Susan Collins of Maine and Bill Cassidy of the Louisiana – for having addressed him against him.
Some experts said that Dr. Monararez marked a clear contrast with Dr. Weldon, whose skeptical opinions on childhood vaccines have aligned themselves with those of Mr. Kennedy and launched alarm in the medical community.
Mr. Kennedy’s response to a growing morbillo outbreak in Texas and New Mexico, including his warm recommendation on vaccination, has aroused significant criticisms. Dr. Monararez is an expert in biosyphicity who has supported Covidi vaccines and his selection can report a growing impatience with anti-Vaccine sentiment.
“He has a strong reputation of a solid researcher and expert in infectious diseases,” said dr. Georges Benjamin, executive director of the American Public Health Association.
“It clearly includes public health and the role of government public health,” he said. “I believe that the public health community can work with her in a positive way.”
But Dr. Monararez spent weeks away from Atlanta, where the agency is based. He did not participate in the meetings of all the hands of the agency or offered reassurance to their employees in the last few weeks, according to several CDC employees who have spoken on condition of anonymity for fear of retaliation.
A section of comments on the agency’s internal website has been quickly eliminated after staff members started noting that they wanted more communications from her.
The directors of the Center played the executive orders of the President and the various instructions of the court with few contributions from the director, the officials said.
Instead, the office of the director of acting was conducted for directives of the White House and the Department of Health and Human Services.
For example, he worked with the cost reduction initiative known as the Government’s efficiency department to plan reductions to the agency, according to a former official with knowledge of the matter.
And when the Trump administration ordered the CDC to break down the pages from its website containing phrases such as “LGBTQ” and “Transgender”, Dr. Monararez did not resist or attempted to preserve important data, according to three people with knowledge of the events, who spoke on condition of anonymous for fear of the relief.